Infinity Pharmaceuticals Inc $10.15

down -0.45


17/4/2014 08:10 PM  |  NASDAQ : INFI  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INFI Trend Analysis - it has underperformed the S&P 500 by 95%

Partner Headlines

  1. The Top Five Drug Launches Of 2013

    IBD
  2. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on Limited Clinical ...

    Benzinga
  3. Benzinga's Top Downgrades

    Benzinga
  4. Celgene's stock hits new high

    IBD
  5. Mid-Day Market Update: Sysco Shares Rise Following Merger with US Foods; ...

    Benzinga
  6. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  7. Benzinga's Volume Movers

    Benzinga
  8. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  9. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH

    Benzinga
  10. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH 2013

    Benzinga
  11. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals on ...

    Benzinga
  12. Benzinga's Top Initiations

    Benzinga
  13. The Best Small Cap Performers of 2012

    Benzinga
  14. Stocks Hitting 52-Week Highs

    Benzinga
  15. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  16. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  17. Infinity Announces Closing of Public Offering and Exercise of Over-Allotment ...

    Benzinga
  18. Stocks Hitting 52-Week Highs

    Benzinga
  19. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  20. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond Foods Falls

    Benzinga
  21. Infinity Pharma Shares Rebound Over $22 Following Phase I Data on IPI-145

    Benzinga
  22. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold on Limited ...

    Benzinga
  23. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  24. Stocks Hitting 52-Week Highs

    Benzinga
  25. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at Hold; Royalty ...

    Benzinga
  26. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  27. Health Care Sector Wrap

    FoxBusiness
  28. Synacor, American Capital Mortgage Investment Crp, Other Stocks Hit 52-Week ...

    FoxBusiness
  29. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  30. Morning Market Losers

    Benzinga
  31. Benzinga's Top Pre-Market Losers

    Benzinga
  32. A Peek Into The Market Before The Trading Starts

    Benzinga
  33. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  34. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  35. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  36. Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine ...

    Benzinga
  37. Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients ...

    Benzinga
Trading Center